BRITISH MEDICAL JOURNAL 8 MARCH 1975 (aged 24-50) were then visited without prior waring and their height and weight -easured. Their report heights and weights were on average 05 in (12-7 n) above and 6-1 lb (3'13 kg) below their actual measurements. As in Ashwell and Etchell's paper, overweight was assessed using the Metrpolitan Life Insurance Company tables.2 For 90% of the women the reported measurements indicated a lower degree of overwetght than the actual measurements, the difference being roughly proportional to the degree of overweight.
SI Units
SiR-If and when SI units are introduced into clinical practice I focesee very real difficulties in the management of patients.
Apaat from the expense involved in convert- ing to SI, the nmanagement of -common diseases is surely going to be very much inore difficult. When one is informed that a patient in diabetic ketoacidosis bas a blood sugar of 780 mg/ 100 ml one has an.istant picture of what that patient's dinical state is likely to be. The SI unit nornul range of blood sugar is 30-5$0 mnmol/l and we are told that the approximate range found in hospital practice could vary from 06 to 60 xmmol/l. It will not be easy to decide Qn insulin dosage in such patients. I would tlink that the same difficulties would wise in uraemic patients w!hen the blood urea is measured in Si unis.
We are-told that presribing will not be changed to SI; neither will blood pressurerecrdings. These 1-1 g/l (110 mg/100 ml) (normal 0-9-4 5 g/l), and IgM 0-34 g/l (34 mg/100 ml) (normal 0-6-2-8 g/l). The Sia test for macroglobulins was negative and no cryoglobulins were detected. Bone marrow examination showed a marked increase in mature plasma cells with depressed erythropoiesis, and the haemoglobin level later dropped to 7-9 g/dl. Serum calcium was normal at 2 45 mmol/l (9-8 mg/100 ml) but serum phosphate was increased to 2-5 mmol/l (7-8 mg/100 ml) owing to renal failure. Serum urate was 79-7 mmol/l (13-4 mg/100 ml). Skeletal survey, which included x-rays of chest, pelvis, upper femora, skull, mandible, humeri, and dorsolumbar spine, showed no evidence of myeloma. On intravenous fluids her blood urea began to fall and with further treatment it dropped to 8-9 mmol/l (54 mg/100 ml). She was treated with intermittent courses of melphalan and prednisolone with complete disappearance from her urine of Bence Jones protein. The total plasma protein dropped to 73 g/l (7-3 g/100 ml), albumin 32 g/l (3-2 g/100 ml), and globulin 41 g/l (4-1 g/100 ml) and the electrophoretic band due to abnormal protein became faint. IgG fell to 36 g/l (3 600 mg/100 ml). There was a remarkable improvement in her gangrene.
The incidence of venous gangrene in multiple myeloma is rare and it is interesting to note the remarkable improvement of the gangrene in this elderly woman with the treatment of multiple myeloma alone and without any surgical intervention. In view of the good arterial supply to the feet the superficial gangrene was attributable to ooclusion of venules associated with the high level of IgG and hypothermia. New Causes of Malignant Hyperpyrexia SiR,-Dr. J. A. Lack (4 January, p. 36) raised the possibility of inadvertent adnministration of halotihane to a patient who developed malignant hyperpyrexia with nitrous oxide.' He pointed out that balothane would be present in the gas delivered from most anaesthetic machines due to halothane liberated from rubber breathing tubes, etc. Other sources of contamination have been found such as elastomeric seals and certain rigid plastics within anaesthetic apparatus.2
As we were aware of this danger we took the following precautions: (1) the vaporizer was removed from the machine (a conventional B.O.C. Mk II Boyle's machine); (2) all rubber tubing, rubber connexions, and mask were brand new; and (3) the machine was purged with a nitrous oxide/oxygen gas mixture at a flow rate of 8 1/min for about 30 minutes before induction of anaesthesia. It could be argued that even with these precautions enough halothane could still be present to induce malignant hyperpyrexia. However, during the third anaesthetic given to the patient-, which consisted of thiopentone without nitrous oxide, oxygen was administered from the same machine and no pyrexia occurred. A second patient, the above patient's homozygous twin, received a thiopentone/oxygen anaesthetic similarly with no rise in temperature.
There is a potenitial danger to patients highly susceptible to halothane in leaving the vaporizer on the machine even though it is in the "off" position. On a hot morning in June 1973 we anaesthetized a third patient susceptible to malignant hyperpyrexia using an anaesthetic machine with the halothane vaporizer (Fluotec Mk II) in the "off" position. The patient developed a low-grade pyrexia towards the end of the procedure, which had lasted 1' hours, and on investigation a faint smell of halothane vapour was detected in the gas mixture. A Hook and Tucker ultraviolet halothane meter indicated that a low but measurable concentration of halothane was present (less than 0 25% v/v). Professor J. S. Robinson and his colleagues in the University of BirTmingham investigated our suspect vaporizer in their laboratory under similar conditions and found that there was a oonstant leak of halothane vapour of betweetn 4 and 9 p.p.m. v/v. However, when the gas flow was first turned on comparatively high levels of halothane vapour were delivered; initial concentrations were well in excess of 123 p.p.m. v/v and fell rapidly to 10 p.p.m. v/v after 15 minutes. The effect of a rising ambient temperature (as we had experienced during the anaesthetic) was to almost double the constant leak. Professor Robinson and his colleagues have described their analytical technique.3
In the light of more recent experience it is impossible to know whether the low grade pyrexia in the third patient was due to' nitrous oxide, low concentrations of halothane, both these drugs acting together, In the hope of reducing adverse side effects of oral contraceptives many practitioners will transfer patients to these new products. An important problem for such women is to determine whether the sudden reduction in dose is associated with "escape" ovulations during the first cycle of treatment with a low-dose preparation.
We have investigated this problem in 10 healthy young women who were switched from high-dose products (Gynovlar (3 mg norethisterone acetate + 50 jig ethynylestradiol) or Nordiol (250 ,ug D-norgestrel + 50 jig ethynylestradiol)) to a new low-dose prepairation, Nordette (150 jig D-norgestrel + 30 jig ethynylestradiol). Venous blood specimens were collected daily during the first treatment cycle following the change in medication. Plasma progesterone and luteinizing hormone (LH) were measured by specific radioimmunoassays. Progesterone concentration did not exceed 0 9 ,ug/l in any ,specimen, while LH concentration remained below 21 
